Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJW47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,002
Award facts
- Contract value 100% obligated
- $54,001.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54,001.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections (0.5 ml). This is a non-set-aside competitive award with a completion date of September 11, 2025, and performance to be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026 and serves as a comprehensive pharmaceutical and medical supply vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant portfolio of federal medical contracts with the Defense Logistics Agency and its Medical Supply Chain. The company's extensive experience includes supplying a broad range of pharmaceutical products—from specialty medications and vaccines to brand-name and generic drugs—to support military and veteran healthcare systems, the Defense Health Agency, and the U.S. Coast Guard. This award for Zepbound, a diabetes medication, aligns with the company's demonstrated capability to fulfill federal medical procurement requirements through open competition and reflects its critical role in supporting the military health system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJW47?
SPE2DB25FJW47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FJW47 worth?
The government has obligated $54,002 on SPE2DB25FJW47.
Is contract SPE2DB25FJW47 an order under another contract?
Yes. SPE2DB25FJW47 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJW47 competed?
The extent of competition for SPE2DB25FJW47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award